Reduced cerebrovascular CO(2) reactivity in CADASIL: A transcranial Doppler sonography study
- PMID: 11136908
- DOI: 10.1161/01.str.32.1.17
Reduced cerebrovascular CO(2) reactivity in CADASIL: A transcranial Doppler sonography study
Abstract
Background and purpose: Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukencephalopathy (CADASIL) is a hereditary angiopathy caused by mutations in Notch3. Cerebral microvessels show an accumulation of granular osmiophilic material in the vicinity of degenerating vascular smooth muscle cells. To study cerebrovascular function in CADASIL, we performed measurements on cerebral hemodynamics by using transcranial Doppler sonography.
Methods: Middle cerebral artery (MCA) mean blood flow velocity (MFV), cerebrovascular CO(2) reactivity, and the resistance index were measured by bilateral transcranial Doppler sonography in 29 CADASIL individuals (mean age, 49.0+/-2.4 years) and an equal number of age- and sex-matched control subjects.
Results: Compared with control subjects, CO(2) reactivity was reduced in CADASIL (33.4+/-2.7% versus 45.3+/-3.0%; P:<0.01). This difference remained significant when only nondisabled CADASIL individuals (Rankin=0, n=21) were included in the analysis (P:<0.05). CO(2) reactivity was significantly lower in disabled than in nondisabled CADASIL individuals (24.5+/-2.7% versus 36.8+/-3.4%; P:<0.05). MCA MFV was reduced in CADASIL (45.6+/-2.2 cm/s versus 54.2+/-2.4 cm/s; P:<0.05) and correlated negatively with age both in affected individuals (r=-0.314; P:<0.05) and control subjects (r=-0.339; P:<0.05). Resistance index was not significantly altered (59.0+/-1.0% versus 57.7+/-1.2%; P:=0.42).
Conclusions: In CADASIL, there is a reduction of both CO(2) reactivity and basal MCA MFV. The reduced CO(2) reactivity suggests functional impairment of cerebral vasoreactivity probably related to vascular smooth muscle cell dysfunction. The reduction of CO(2) reactivity in nondisabled CADASIL individuals suggests an early role of impaired cerebral vasoreactivity in the evolution of the disease.
Similar articles
-
Prolonged cerebral transit time in CADASIL: a transcranial ultrasound study.Stroke. 2002 Feb;33(2):509-12. doi: 10.1161/hs0202.102949. Stroke. 2002. PMID: 11823661 Clinical Trial.
-
Impaired cerebral vasoreactivity in a transgenic mouse model of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy arteriopathy.Stroke. 2005 May;36(5):1053-8. doi: 10.1161/01.STR.0000163080.82766.eb. Epub 2005 Apr 7. Stroke. 2005. PMID: 15817893
-
Acetazolamide improves cerebral hemodynamics in CADASIL.J Neurol Sci. 2010 May 15;292(1-2):77-80. doi: 10.1016/j.jns.2010.01.023. Epub 2010 Mar 12. J Neurol Sci. 2010. PMID: 20227091
-
CADASIL: a common form of hereditary arteriopathy causing brain infarcts and dementia.Brain Pathol. 2002 Jul;12(3):371-84. doi: 10.1111/j.1750-3639.2002.tb00451.x. Brain Pathol. 2002. PMID: 12146805 Free PMC article. Review.
-
CADASIL: hereditary arteriopathy leading to multiple brain infarcts and dementia.Ann N Y Acad Sci. 2000 Apr;903:273-84. doi: 10.1111/j.1749-6632.2000.tb06377.x. Ann N Y Acad Sci. 2000. PMID: 10818516 Review.
Cited by
-
Consensus statement for diagnosis of subcortical small vessel disease.J Cereb Blood Flow Metab. 2016 Jan;36(1):6-25. doi: 10.1038/jcbfm.2015.172. J Cereb Blood Flow Metab. 2016. PMID: 26198175 Free PMC article. Review.
-
Impairment of cerebrovascular reactivity in response to hypercapnic challenge in a mouse model of repetitive mild traumatic brain injury.J Cereb Blood Flow Metab. 2021 Jun;41(6):1362-1378. doi: 10.1177/0271678X20954015. Epub 2020 Oct 13. J Cereb Blood Flow Metab. 2021. PMID: 33050825 Free PMC article.
-
SARS-CoV-2 infection activating a novel variant of the NOTCH3 gene and subsequently causing development of CADASIL.Arch Med Sci. 2022 Apr 4;19(6):1781-1794. doi: 10.5114/aoms/146978. eCollection 2023. Arch Med Sci. 2022. PMID: 38058732 Free PMC article.
-
Microembolic signals in systemic lupus erythematosus and other cerebral small vessel diseases.J Neurol. 2010 Apr;257(4):503-8. doi: 10.1007/s00415-009-5421-y. Epub 2009 Dec 24. J Neurol. 2010. PMID: 20033202 Review.
-
Nimodipine augments cerebrovascular reactivity in aging but runs the risk of local perfusion reduction in acute cerebral ischemia.Front Aging Neurosci. 2023 Apr 27;15:1175281. doi: 10.3389/fnagi.2023.1175281. eCollection 2023. Front Aging Neurosci. 2023. PMID: 37181624 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous